Lindbrook Capital’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$8.17K Sell
638
-455
-42% -$7.3K ﹤0.01% 1737
2024
Q4
$19.3K Buy
1,093
+646
+145% +$12.3K ﹤0.01% 1302
2024
Q3
$10.2K Buy
447
+420
+1,556% +$9.49K ﹤0.01% 1664
2024
Q2
$620 Sell
27
-124
-82% -$3.82K ﹤0.01% 2573
2024
Q1
$5.98K Buy
+151
New +$5.97K ﹤0.01% 1821
2022
Q3
Sell
-46
Closed -$2K 2819
2022
Q2
$2K Buy
46
+37
+411% +$1.34K ﹤0.01% 2011
2022
Q1
$0 Buy
+9
New +$352 ﹤0.01% 2569

Other funds holding NRC

Lindbrook Capital's NRC Position: Q1 2025 in Review

Lindbrook Capital reduced its NRC Health Common Stock (NRC) stake by 42% in Q1 2025, selling an estimated $7.3K and leaving 638 shares worth $8.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1737.

Lindbrook Capital first reported a position in NRC in Q1 2022 and has held it in 7 quarters since. The position peaked at $19.3K in Q4 2024. 123 funds tracked by Wall St. Rank hold NRC as of Q1 2025.

  • Lindbrook Capital held 638 shares of NRC Health Common Stock worth $8.17K as of Q1 2025.
  • Lindbrook Capital sold 455 NRC Health Common Stock shares in Q1 2025, an estimated $7.3K.
  • NRC Health Common Stock made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1737 holding.
  • Lindbrook Capital first reported a position in NRC Health Common Stock in Q1 2022 and has held it in 7 quarters since.
  • Lindbrook Capital's NRC Health Common Stock position peaked at $19.3K in Q4 2024.
  • 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.